Provided by Tiger Fintech (Singapore) Pte. Ltd.

COMPASS Pathways plc

4.34
-0.0100-0.23%
Post-market: 4.400.0600+1.38%16:42 EDT
Volume:2.52M
Turnover:11.07M
Market Cap:406.06M
PE:-2.23
High:4.53
Open:4.27
Low:4.14
Close:4.35
Loading ...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ramsay Health Care (OtherRMSYF) and COMPASS Pathways (CMPS)

TIPRANKS
·
04 Mar

Analysts Offer Insights on Healthcare Companies: COMPASS Pathways (CMPS) and Rani Therapeutics Holdings (RANI)

TIPRANKS
·
02 Mar

COMPASS Pathways plc (CMPS): Among the Best Psychedelic Stocks to Buy in 2025

Insider Monkey
·
02 Mar

Compass Pathways PLC reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
01 Mar

Compass Pathways Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
28 Feb

Compass Pathways price target lowered to $15 from $23 at Canaccord

TIPRANKS
·
28 Feb

Compass Pathways PLC (CMPS) Q4 2024 Earnings Call Highlights: Strategic Financing and R&D ...

GuruFocus.com
·
28 Feb

Compass Pathways Plc (CMPS) Q4 2024 Earnings Call Transcript

Motley Fool Transcribing
·
28 Feb

Stifel Nicolaus Initiates Coverage on COMPASS Pathways With Buy Rating, $11 Price Target

MT Newswires Live
·
27 Feb

Compass Pathways Q4 2024 GAAP EPS $(0.63) Misses $(0.62) Estimate, Cash And Equivalents $165.1M

Benzinga
·
27 Feb

BRIEF-COMPASS Pathways Q4 EPS USD -0.63

Reuters
·
27 Feb

Compass Pathways initiated with a Buy at Stifel

TIPRANKS
·
27 Feb

Compass Pathways to Participate in TD Cowen 45th Annual Health Care Conference

Business Wire
·
26 Feb

Compass Pathways PLC expected to post a loss of 62 cents a share - Earnings Preview

Reuters
·
25 Feb

BRIEF-Compass Pathways To Announce Q4 And FY Results On Feb 27, 2025

Reuters
·
18 Feb

Press Release: Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Dow Jones
·
18 Feb

Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference

Business Wire
·
05 Feb

Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.

Dow Jones
·
05 Feb